Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Rheumatoid Arthritis
•
Primary Care
For patients with obesity and elevated alk phos who have RA, do you check a fibroscan or serum NASH fibrosure test before starting methotrexate or leflunomide?
Related Questions
How do you approach treatment intensification in patients with RA and low disease activity but not in remission, considering the potential risks of increased immunosuppression?
How do you approach the management of a patient with RA on methotrexate who has gingivitis or or frequent cavities?
How do you manage oral ulcers as a side effect from leflunomide?
Do you still consider the use of pegloticase in someone with substantial tophaceous burden despite optimal uric acid levels?
How do you approach management of patients with RA who have paradoxical eczematous reaction while on TNF inhibitor?
What therapies have you found most effective for JAK-induced/associated acne (JAKcne)?
How do you approach diagnosis in a patient with inflammatory joint symptoms and isolated bilateral CMC joint erosions on x-ray imaging?
How can we approach tapering or discontinuing biologic DMARDs in patient in their 80s with well controlled rheumatoid arthritis?
For patients who do not have access to biologic therapies, what are some csDMARD combination pearls or tips that you have that have particular efficacy in different rheumatologic diseases?
Can inflammatory arthritis develop in patients with a history of chronic hepatitis B?
